In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.